Legends
TABLE 1 Patients’ characteristics
TABLE 2 Procedural details and outcomes
FIGURE 1 Images of ultrasound-guided placement of TIVAP via the
right BCV in a 25-month-old child with retinoblastoma.
A: The ultrasound probe was placed in the right supraclavicular region
to obtain a longitudinal view of the right BCV (*), and the access
needle (white arrows) was advanced into the BCV. B: Fluoroscopy at
procedure end shows that the
injection port was implanted in
the right infraclavicular area, and the catheter tip (white arrow) was
located at the cavoatrial junction. C: The skin incision
of
venipuncture is located in
supraclavicular site close to the neck, measuring 3-mm-length; the port
pocket incision is located in upper chest wall, measuring approximately
2-cm-length, respectively. (☆Indicates the lung.)
FIGURE 2 Clinical process of
subcutaneous hematoma after TIVAP
implantation in a 2-month-old, 6.3-kg-weighted infant with acute
lymphoblastic leukemia.
A: During the first week after surgery, the hematoma adjacent to the
port pocket and tunnel was confirmed by ultrasound, which enlarged
progressively. B, C: Wet compress with 25% magnesium sulfate solution
and a transparent patch followed by elastic bandage for pressure
dressing was applied for 3 days. D: Hematoma resolved two months later.
(White arrow indicates the skin incision at the venipuncture site.)